Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

NeuroMET mini symposium October 2018

05 Nov 2018

The third NeuroMET mini symposium was held at the Institute for Regenerative Medicine & Biotherapy, Montpellier, France, on October 24, 2018. It was attended by Consortium members and stakeholders from clinical laboratories, industry and academia.

Following a brief introduction to NeuroMET, the symposium included sessions on MRI, patient-centred outcome measures and biomarkers, and prompted much discussion between the participants.

Find more details of the presentations below.


Correlations Between Changes of Different MRI derived Biomarkers in Alzheimer's
Disease: An Update on Preliminary Results from the NeuroMET project
- Ariane Fillmer, Physikalisch-Technische Bundesanstalt, Berlin

Quality assured Patient-Centred Outcome Measures,
- Leslie Pendrill, RI:SE, Göteburg

An update on the development of a reference measurement procedure for
quantification of α-synuclein in CSF.
- Adam Cryar, LGC, Teddington

The NeuroMET contribution towards standardisation of total tau measurements
- Amandine Boeuf, LNE, Paris

Implementation of standard additions to determine endogenous analyte concentrations by immunoassays to overcome biological matrix interference
- Susan Pang, LGC, Teddington

Profiling of intact proteins in the CSF of Alzheimer's disease patients using top-down
clinical proteomics: revealing specific isoform biomarker candidates
- Christophe Hirtz, CHU Montpellier, Montpellier